Keyphrases
Israel
100%
Extended-spectrum-lactamase
53%
Bloodstream Infection
53%
Enterobacteriaceae
52%
Israeli
47%
Carbapenem-resistant Enterobacteriaceae
37%
Escherichia Coli
35%
Klebsiella Pneumoniae Carbapenemase
27%
Klebsiella Pneumoniae (K. pneumoniae)
25%
Antimicrobial Resistance
25%
Carbapenemase-producing Enterobacterales
23%
Acute Hospital
22%
Methicillin-resistant Staphylococcus Aureus
22%
Infection Control
22%
KPC-2
22%
ESBL-producing Enterobacteriaceae
19%
Confidence Interval
19%
Bacteremia
19%
National Survey
19%
Risk Factors
19%
Healthcare Workers
18%
Post-acute Care
18%
Odds Ratio
16%
Plasmid
15%
COVID-19
15%
OXA-48
14%
Carbapenem-resistant Acinetobacter Baumannii
14%
Empirical Therapy
14%
Carbapenem Resistance
13%
Carbapenems
13%
Long-term Care Facilities
13%
National Policy
12%
Enterobacter
12%
Pseudomonas Aeruginosa (P. aeruginosa)
11%
Carbapenemase
11%
Infection Prevention
11%
United States
11%
Epidemiology
10%
Producing Escherichia Coli
10%
Infection Rate
10%
Hospital Admission
9%
30-day Mortality
9%
Retrospective Cohort Study
9%
Rehabilitation Centers
9%
Neonatal Intensive Care Unit
9%
Tel Aviv
9%
Cephalosporin Resistance
8%
COVID-19 Pandemic
8%
ESBL-E
8%
Antibiotics
8%
Medicine and Dentistry
Enterobacteriaceae
42%
Penicillinase
41%
Bloodstream Infection
40%
Carbapenem-Resistant Enterobacteriaceae
31%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
25%
Extended Spectrum Beta Lactamase
24%
Infection
23%
Antibiotic Resistance
23%
Infection Control
21%
Prevalence
17%
Carbapenem
16%
Antiinfective Agent
16%
COVID-19
14%
Klebsiella pneumoniae
13%
Odds Ratio
12%
Subacute Care
12%
Escherichia coli
12%
Long-Term Care
11%
Pathogen
11%
Acinetobacter Baumannii
11%
Infection Prevention
11%
Carbapenem Derivative
11%
Public Health
10%
Rehabilitation Center
9%
Health Care
8%
Carbapenemase
7%
Enterobacter
7%
Cohort Analysis
7%
Catheter Infection
7%
Sepsis
7%
Hand Hygiene
7%
Cohort Effect
6%
Quinolone Derivative
6%
Blood Culture
6%
Methicillin Resistant Staphylococcus Aureus
6%
Carbapenemase Producing Enterobacteriaceae
6%
Pneumococcal Pneumonia
6%
Streptococcus pneumonia
6%
Lactam
6%
Intensive Care Unit
6%
Antibiotics
5%
Emergency Care
5%
Systematic Review
5%
Targeted Therapy
5%